- Home
- Publications
- Publication Search
- Publication Details
Title
Next-Generation Vaccines Based on Bacille Calmette–Guérin
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-02-05
DOI
10.3389/fimmu.2018.00121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Observational study to estimate the changes in the effectiveness of bacillus Calmette–Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
- (2017) Punam Mangtani et al. HEALTH TECHNOLOGY ASSESSMENT
- Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model
- (2017) Martin Rao et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Novel approaches to tuberculosis vaccine development
- (2017) Stefan H.E. Kaufmann et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice
- (2017) Zhidong Hu et al. MOLECULAR THERAPY
- Latently and uninfected healthcare workers exposed to TB make protective antibodies againstMycobacterium tuberculosis
- (2017) Hao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice
- (2017) Mushtaq Ahmed et al. VACCINE
- Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
- (2017) Nacho Aguilo et al. Nature Communications
- Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice
- (2017) Han-Gyu Choi et al. Oncotarget
- Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection
- (2017) Matthias I. Gröschel et al. Cell Reports
- Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70
- (2017) Fu-Ying Dai et al. Human Vaccines & Immunotherapeutics
- Vaccine-elicited memory CD4+ T cell expansion is impaired in the lungs during tuberculosis
- (2017) Stephen M. Carpenter et al. PLoS Pathogens
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- Immune Responses to Bacillus Calmette–Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?
- (2017) Juan I. Moliva et al. Frontiers in Immunology
- A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
- (2017) Jilei Ma et al. EBioMedicine
- Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
- (2017) Ivan P. Nascimento et al. Scientific Reports
- A Functional Role for Antibodies in Tuberculosis
- (2016) Lenette L. Lu et al. CELL
- In VitroExperimental Model of Trained Innate Immunity in Human Primary Monocytes
- (2016) Siroon Bekkering et al. Clinical and Vaccine Immunology
- T-cell exhaustion in tuberculosis: pitfalls and prospects
- (2016) Nargis Khan et al. CRITICAL REVIEWS IN MICROBIOLOGY
- ESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo
- (2016) Andreas Kupz et al. JOURNAL OF CLINICAL INVESTIGATION
- Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
- (2016) Patrick Nguipdop-Djomo et al. LANCET INFECTIOUS DISEASES
- Post-exposure vaccination with the vaccine candidate Bacillus Calmette–Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis
- (2016) Martin Gengenbacher et al. MICROBES AND INFECTION
- Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice
- (2016) Enzhuo Yang et al. MICROBIAL PATHOGENESIS
- Ipr1 modified BCG as a novel vaccine induces stronger immunity than BCG against tuberculosis infection in mice
- (2016) Yuwei Wang et al. Molecular Medicine Reports
- IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis
- (2016) S Venkatasubramanian et al. Mucosal Immunology
- Vaccination for Mycobacterium tuberculosis infection: reprogramming CD4 T-cell homing into the lung
- (2016) D L Barber Mucosal Immunology
- Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
- (2016) J S Woodworth et al. Mucosal Immunology
- ESX secretion systems: mycobacterial evolution to counter host immunity
- (2016) Matthias I. Gröschel et al. NATURE REVIEWS MICROBIOLOGY
- TB vaccine development and the End TB Strategy: importance and current status
- (2016) Helen A. Fletcher et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations
- (2016) S. Sharpe et al. TUBERCULOSIS
- Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis
- (2016) Mohd Saqib et al. TUBERCULOSIS
- KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults
- (2016) Mardi C. Boer et al. TUBERCULOSIS
- Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG Δ ureC :: hly Improves Protection against Tuberculosis
- (2016) Martin Gengenbacher et al. mBio
- Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
- (2016) Carolina Perdomo et al. mBio
- Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
- (2016) Helen A. Fletcher mBio
- Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
- (2016) Kristin L. Griffiths et al. Nature Communications
- Non-specific immunological effects of selected routine childhood immunisations: systematic review
- (2016) Rama Kandasamy et al. BMJ-British Medical Journal
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- Non-specific immunological effects of selected routine childhood immunisations: systematic review
- (2016) Rama Kandasamy et al. BMJ-British Medical Journal
- Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
- (2016) Daniel F. Hoft et al. EBioMedicine
- Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis
- (2016) Timothy Lahey et al. PLoS One
- A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection
- (2015) Xuefeng Yuan et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Optimal Duration of Anti-TB Treatment in Patients With Diabetes
- (2015) Jann-Yuan Wang et al. CHEST
- B cells and antibodies in the defense againstMycobacterium tuberculosisinfection
- (2015) Jacqueline M. Achkar et al. IMMUNOLOGICAL REVIEWS
- Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment
- (2015) Courtney M Yuen et al. LANCET
- Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis
- (2015) Peter Sander et al. VACCINE
- Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system
- (2015) Daria Bottai et al. VACCINE
- Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
- (2015) E. Stylianou et al. VACCINE
- Comparative Genomics of Field Isolates of Mycobacterium bovis and M. caprae Provides Evidence for Possible Correlates with Bacterial Viability and Virulence
- (2015) José de la Fuente et al. PLoS Neglected Tropical Diseases
- Lung-Residing Myeloid-derived Suppressors Display Dual Functionality in Murine Pulmonary Tuberculosis
- (2014) Julia K. Knaul et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cell-to-Cell Transfer of M. tuberculosis Antigens Optimizes CD4 T Cell Priming
- (2014) Smita Srivastava et al. Cell Host & Microbe
- The BCG replacement vaccine VPM1002: from drawing board to clinical trial
- (2014) Stefan HE Kaufmann et al. Expert Review of Vaccines
- Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
- (2014) I Abubakar et al. HEALTH TECHNOLOGY ASSESSMENT
- Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis
- (2014) J. O. Jurado et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma-Homing CD4 T Cells
- (2014) S. Sakai et al. JOURNAL OF IMMUNOLOGY
- Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
- (2014) Alexis Vogelzang et al. JOURNAL OF INFECTIOUS DISEASES
- The Recombinant BCG ΔureC::hlyVaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation
- (2014) Hiroyuki Saiga et al. JOURNAL OF INFECTIOUS DISEASES
- Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges
- (2014) Peter Aaby et al. NATURE IMMUNOLOGY
- Attrition of T-Cell Functions and Simultaneous Upregulation of Inhibitory Markers Correspond with the Waning of BCG-Induced Protection against Tuberculosis in Mice
- (2014) Subhadra Nandakumar et al. PLoS One
- BCG-induced protection: Effects on innate immune memory
- (2014) Mihai G. Netea et al. SEMINARS IN IMMUNOLOGY
- Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis
- (2014) Daryan A. Kaveh et al. VACCINE
- BCG Δzmp1 vaccine induces enhanced antigen specific immune responses in cattle
- (2014) Bhagwati Khatri et al. VACCINE
- Dietary Pyridoxine Controls Efficacy of Vitamin B6-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guerin ureC::hly pdx1 in Mice
- (2014) M. Gengenbacher et al. mBio
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
- (2014) A. Roy et al. BMJ-British Medical Journal
- Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
- (2014) Stefan H E Kaufmann et al. Lancet Respiratory Medicine
- The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. tuberculosis
- (2014) Kris Huygen Frontiers in Immunology
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1- IL-2-Secreting Central Memory Cells
- (2013) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity
- (2013) Johanneke Kleinnijenhuis et al. Journal of Innate Immunity
- Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice
- (2013) Qi Xin et al. PLoS One
- The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice
- (2013) Martin Rao et al. PLoS One
- Prime–boost approaches to tuberculosis vaccine development
- (2012) Neha Dalmia et al. Expert Review of Vaccines
- Urease Activity Represents an Alternative Pathway for Mycobacterium tuberculosis Nitrogen Metabolism
- (2012) Wenwei Lin et al. INFECTION AND IMMUNITY
- Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory Subset
- (2012) Thomas Lindenstrøm et al. INFECTION AND IMMUNITY
- The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
- (2012) Rolf Billeskov et al. PLoS One
- Tuberculosis and Poverty: Why Are the Poor at Greater Risk in India?
- (2012) Olivia Oxlade et al. PLoS One
- Listeriolysin O: the Swiss army knife of Listeria
- (2012) Mélanie Anne Hamon et al. TRENDS IN MICROBIOLOGY
- The recombinant tuberculosis vaccine rBCG ΔureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells
- (2012) Maura Farinacci et al. VACCINE
- Bovine tuberculosis vaccine research: Historical perspectives and recent advances
- (2012) W. Ray Waters et al. VACCINE
- Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model
- (2012) Alberto R. Cervantes-Villagrana et al. VACCINE
- Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
- (2012) Tom H. M. Ottenhoff et al. PLoS Pathogens
- Th1 Cytokine-Secreting RecombinantMycobacterium bovisBacillus Calmette-Guérin and Prospective Use in Immunotherapy of Bladder Cancer
- (2011) Yi Luo et al. Clinical & Developmental Immunology
- Relief from Zmp1-Mediated Arrest of Phagosome Maturation Is Associated with Facilitated Presentation and Enhanced Immunogenicity of Mycobacterial Antigens
- (2011) Pål Johansen et al. Clinical and Vaccine Immunology
- For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection
- (2011) Anca Dorhoi et al. IMMUNOLOGICAL REVIEWS
- The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection
- (2011) Philana Ling Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens
- (2011) Stephen T. Reece et al. VACCINE
- Field Evaluation of the Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin against Bovine Tuberculosis in Neonatal Calves in Ethiopia
- (2010) G. Ameni et al. Clinical and Vaccine Immunology
- Phenotypic Definition of Effector and Memory T-Lymphocyte Subsets in Mice Chronically Infected with Mycobacterium tuberculosis
- (2010) M. I. Henao-Tamayo et al. Clinical and Vaccine Immunology
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis
- (2010) Karen R. Jacobson et al. CLINICAL INFECTIOUS DISEASES
- Surface Expression of MPT64 as a Fusion with the PE Domain of PE_PGRS33 Enhances Mycobacterium bovis BCG Protective Activity against Mycobacterium tuberculosis in Mice
- (2010) M. Sali et al. INFECTION AND IMMUNITY
- Development of a Skin Test for Bovine Tuberculosis for Differentiating Infected from Vaccinated Animals
- (2010) A. O. Whelan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Coadministration of Interleukins 7 and 15 with Bacille Calmette‐Guérin Mounts Enduring T Cell Memory Response againstMycobacterium tuberculosis
- (2010) Vijender Singh et al. JOURNAL OF INFECTIOUS DISEASES
- Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-α induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice
- (2010) Hongbo Shen et al. MICROBIOLOGY AND IMMUNOLOGY
- Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection
- (2010) W. W. Reiley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- Role of risk factors and socio-economic status in pulmonary tuberculosis: a search for the root cause in patients in a tertiary care hospital, South India
- (2010) Soham Gupta et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- The Achilles heel of BCG
- (2010) Ian M. Orme TUBERCULOSIS
- The Type I NADH Dehydrogenase of Mycobacterium tuberculosis Counters Phagosomal NOX2 Activity to Inhibit TNF-α-Mediated Host Cell Apoptosis
- (2010) Jessica L. Miller et al. PLoS Pathogens
- Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
- (2009) Susan W Barnett et al. AIDS
- ESX/type VII secretion systems and their role in host–pathogen interaction
- (2009) Roxane Simeone et al. CURRENT OPINION IN MICROBIOLOGY
- A role for IL-18 in protective immunity againstMycobacterium tuberculosis
- (2009) Bianca E. Schneider et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
- (2009) David J. M. Lewis et al. PLoS One
- Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis
- (2009) G. Lopez-Valencia et al. RESEARCH IN VETERINARY SCIENCE
- Regions of Differences Encoded Antigens as Targets for Immunodiagnosis of Tuberculosis in Humans
- (2009) O. Parkash et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs
- (2009) Bappaditya Dey et al. VACCINE
- Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
- (2009) Ronggai Sun et al. VACCINE
- Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime–boost regimen
- (2009) Yasir A.W. Skeiky et al. VACCINE
- A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
- (2009) Crystal Y. Chen et al. PLoS Pathogens
- Mycobacterium tuberculosis Prevents Inflammasome Activation
- (2008) Sharon S. Master et al. Cell Host & Microbe
- A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
- (2008) M. V. Tullius et al. INFECTION AND IMMUNITY
- Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ureC hly+ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis
- (2008) E. Z. Tchilian et al. INFECTION AND IMMUNITY
- Efficacy of Recombinant Bacille Calmette‐Guérin Vaccine Secreting Interleukin‐15/Antigen 85B Fusion Protein in Providing Protection againstMycobacterium tuberculosis
- (2008) Ce Tang et al. JOURNAL OF INFECTIOUS DISEASES
- A New Recombinant Bacille Calmette‐Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis‐Specific Immunity in Human Volunteers
- (2008) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started